These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 30138161)

  • 41. Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
    Furuya-Kanamori L; Doi SA; Paterson DL; Helms SK; Yakob L; McKenzie SJ; Garborg K; Emanuelsson F; Stollman N; Kronman MP; Clark J; Huber CA; Riley TV; Clements AC
    J Clin Gastroenterol; 2017 Feb; 51(2):145-150. PubMed ID: 26974758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals.
    Agrawal M; Aroniadis OC; Brandt LJ; Kelly C; Freeman S; Surawicz C; Broussard E; Stollman N; Giovanelli A; Smith B; Yen E; Trivedi A; Hubble L; Kao D; Borody T; Finlayson S; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):403-7. PubMed ID: 26352106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent
    Rokkas T; Gisbert JP; Gasbarrini A; Hold GL; Tilg H; Malfertheiner P; Megraud F; O'Morain C
    United European Gastroenterol J; 2019 Oct; 7(8):1051-1063. PubMed ID: 31662862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.
    Mamo Y; Woodworth MH; Wang T; Dhere T; Kraft CS
    Clin Infect Dis; 2018 May; 66(11):1705-1711. PubMed ID: 29272401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
    Tariq R; Pardi DS; Bartlett MG; Khanna S
    Clin Infect Dis; 2019 Apr; 68(8):1351-1358. PubMed ID: 30957161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.
    Qazi T; Amaratunga T; Barnes EL; Fischer M; Kassam Z; Allegretti JR
    Gut Microbes; 2017 Nov; 8(6):574-588. PubMed ID: 28723262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The success of fecal microbial transplantation in
    Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
    Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
    [No Abstract]   [Full Text] [Related]  

  • 50. Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.
    Fischer M; Sipe B; Cheng YW; Phelps E; Rogers N; Sagi S; Bohm M; Xu H; Kassam Z
    Gut Microbes; 2017 May; 8(3):289-302. PubMed ID: 28001467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
    Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
    BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series.
    Rubin TA; Gessert CE; Aas J; Bakken JS
    Anaerobe; 2013 Feb; 19():22-6. PubMed ID: 23182843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection.
    Feuerstadt P; Aroniadis OC; Svedlund FL; Garcia M; Stong L; Boules M; Khanna S
    Dig Dis Sci; 2022 Jul; 67(7):2763-2770. PubMed ID: 34275058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience.
    Aroniadis OC; Brandt LJ; Greenberg A; Borody T; Kelly CR; Mellow M; Surawicz C; Cagle L; Neshatian L; Stollman N; Giovanelli A; Ray A; Smith R
    J Clin Gastroenterol; 2016; 50(5):398-402. PubMed ID: 26125460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD; Ajami NJ; Petrosino JF; Jun G; Hanis CL; Shah M; Hochman L; Ankoma-Sey V; DuPont AW; Wong MC; Alexander A; Ke S; DuPont HL
    Aliment Pharmacol Ther; 2017 Apr; 45(7):899-908. PubMed ID: 28220514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
    Chapman BC; Moore HB; Overbey DM; Morton AP; Harnke B; Gerich ME; Vogel JD
    J Trauma Acute Care Surg; 2016 Oct; 81(4):756-64. PubMed ID: 27648772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial experience with fecal microbiota transplantation in Clostridium difficile infection - transplant protocol and preliminary results.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Pinto-Pais T; Fernandes C; Ribeiro I; Rodrigues J; Lopes P; Teixeira T; Carvalho J
    Rev Esp Enferm Dig; 2015 Jul; 107(7):402-7. PubMed ID: 26140631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
    Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
    Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose.
    Allegretti JR; Fischer M; Sagi SV; Bohm ME; Fadda HM; Ranmal SR; Budree S; Basit AW; Glettig DL; de la Serna EL; Gentile A; Gerardin Y; Timberlake S; Sadovsky R; Smith M; Kassam Z
    Dig Dis Sci; 2019 Jun; 64(6):1672-1678. PubMed ID: 30519847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome.
    Camacho-Ortiz A; Gutiérrez-Delgado EM; Garcia-Mazcorro JF; Mendoza-Olazarán S; Martínez-Meléndez A; Palau-Davila L; Baines SD; Maldonado-Garza H; Garza-González E
    PLoS One; 2017; 12(12):e0189768. PubMed ID: 29261736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.